Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found four records

For-profit organization

Agreement:

Synthetic nucleosides as new pharmaceuticals

Agreement Number:

909375

Duration: from Jul 1, 2018 to Feb 29, 2020
Description:

The proposed project involves Stage 1 drug discovery program on synthetic anticancer nucleosides based on Firm's existing technology platform in nucleoside chemistry including a library of nucleoside based molecules, many of which have been of interest to the pharmaceutical industry. Objective is to develop and screen a series of synthetic nucleosides, identify lead candidates and fully characterize them for anticancer properties on human cancer cell lines. Ultimate goal is to discover proprietary anticancer drug candidate/s with high therapeutic index for consideration as a pharmaceutical within the synthetic anticancer nucleosides drug class.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Edmonton, Alberta, CA T5S 1G2

$50,000.00

Feb 13, 2017
Organization: National Research Council Canada
Location: Edmonton, Alberta, CA
Organization: National Research Council Canada
Location: Edmonton, Alberta, CA
Organization: National Research Council Canada
Location: Edmonton, Alberta, CA